234 related articles for article (PubMed ID: 14724575)
1. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Surgery; 2004 May; 135(5):555-62. PubMed ID: 15118593
[TBL] [Abstract][Full Text] [Related]
3. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE
Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
[TBL] [Abstract][Full Text] [Related]
4. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Clin Cancer Res; 2004 Apr; 10(7):2307-18. PubMed ID: 15073106
[TBL] [Abstract][Full Text] [Related]
7. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE
Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity.
Hong KP; Shin MH; Yoon S; Ji GY; Moon YR; Lee OJ; Choi SY; Lee YM; Koo JH; Lee HC; Lee GK; Kim SR; Lee KH; Han HS; Choe KH; Lee KM; Hong JM; Kim SW; Yi JH; Ji HJ; Kim YB; Song HG
Biomaterials; 2015 Oct; 67():32-41. PubMed ID: 26204223
[TBL] [Abstract][Full Text] [Related]
9. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
Duxbury MS; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 May; 317(3):837-43. PubMed ID: 15081416
[TBL] [Abstract][Full Text] [Related]
10. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
Duxbury MS; Ito H; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
Liau SS; Jazag A; Ito K; Whang EE
Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer.
Lee H; Jang Y; Park S; Jang H; Park EJ; Kim HJ; Kim H
Theranostics; 2018; 8(15):4247-4261. PubMed ID: 30128051
[TBL] [Abstract][Full Text] [Related]
14. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Ashley SW; Whang EE
J Biol Chem; 2004 May; 279(22):23176-82. PubMed ID: 15047698
[TBL] [Abstract][Full Text] [Related]
15. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H
J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050
[TBL] [Abstract][Full Text] [Related]
17. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.
Chen J; Li Q; An Y; Lv N; Xue X; Wei J; Jiang K; Wu J; Gao W; Qian Z; Dai C; Xu Z; Miao Y
Int J Oncol; 2013 Sep; 43(3):877-85. PubMed ID: 23857344
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation.
Ilantzis C; DeMarte L; Screaton RA; Stanners CP
Neoplasia; 2002; 4(2):151-63. PubMed ID: 11896570
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma.
Son SM; Yun J; Lee SH; Han HS; Lim YH; Woo CG; Lee HC; Song HG; Gu YM; Lee HJ; Lee OJ
Sci Rep; 2019 Sep; 9(1):11607. PubMed ID: 31474761
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
Pandey R; Zhou M; Islam S; Chen B; Barker NK; Langlais P; Srivastava A; Luo M; Cooke LS; Weterings E; Mahadevan D
Sci Rep; 2019 Dec; 9(1):18347. PubMed ID: 31797958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
